期刊文献+

喹硫平对难治性抑郁症的辅助治疗作用 被引量:1

下载PDF
导出
摘要 目的:探讨喹硫平合并西酞普兰治疗难治性抑郁症的安全性和疗效。方法:采用双盲对照研究,将50例难治性抑郁症的患者随机分为两组,分别以西酞普兰或喹硫平合并西酞普兰治疗,在治疗前和治疗第2、4、6、8周末分别用汉密尔顿抑郁量表(HAMD)和临床疗效总评量表(CGI),及治疗中出现的症状量表(TESS)评定疗效及不良反应。结果:喹硫平联合西酞普兰治疗难治性抑郁症的疗效明显优于单一使用西酞普兰(P<0.05),药物不良反应两组间无显著差异(P>0.05)。结论:喹硫平联合西酞普兰治疗难治性抑郁症的疗效明显优于单一使用西酞普兰,药物不良反应两组间无显著差异。
机构地区 武汉市优抚医院
出处 《中国民康医学》 2010年第17期F0002-F0002,共1页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献3

二级参考文献17

  • 1Yatham LN, Kennedy SH, Odonovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies [ J ]. Bipolar Disord, 2005,7 ( Suppl. 3 ) : 5 -69.
  • 2Hou C ,Jla F, Liu Y, et al. CSF serotonin ,5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder[ J ]. Brain Res ,2006,1095 : 154-158.
  • 3Blier P, Szabo ST. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety [ J]. J. Clin Psychiatry ,2005,66( Suppl. 8 ) :30-40.
  • 4Mintyn MA, Sheline YI, Moerlein SM, et al. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [ 18F] altanserin positron emission tomography [ J ]. Binl Psychiatry ,2004,55:217-224.
  • 5Yatham LN, Goldstein JM, Vieta E, et al. Atypical antipsychotics in bipolar depression : potential mechanisms of action [ J ]. J. Clin Psychiatry ,2005,66( Suppl. 5 ) :40-48.
  • 6Meyer JH, Mcneely HE, Sagrati S, et al. Elevated putamen D ( 2 ) receptor binding potential in major depression with motor retardation : an [ 11C ] raclopride positron emission tomography study [ J ]. Am J Psychiatry ,2006,163:594-602.
  • 7Davies MA, Setola V, Strachan RT, et al. Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies [ J ]. Pharmacogenomics J, 2006,6:42-51.
  • 8Goldstein JM. Quetiapine fumarate (Seroquel) :a new atypical antipsychotic I J]. Drugs Today, 1999,35 : 193-210.
  • 9Diehl D J, Gershon S. The role of dopamine in mood disorders[ J ]. Compr Psychiatry, 1992 33 : 115-120.
  • 10Krystal JH, Sanacora G, Blumberg H, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments [ J ]. Mol Psychiatry,2002,7 ( Suppl. 1 ) -71-80.

共引文献11

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部